Nanopath Inc funding

Nanopath Inc, a biotechnology company based in Cambridge, MA, filed a Form D with the SEC on November 13, 2026 and reported $29.9M raised of a $36.8M offering.

Amount raised$29.9M

Offering size$36.8M

Filed with the SECNovember 13, 2026

First saleOctober 22, 2026

IndustryBiotechnology

SecuritiesEquity, Debt

LocationCambridge, MA

FoundedMore than 5 years ago

Entity typeCorporation

Investors so far21

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Nov 13

Other health care rounds in Massachusetts

Zai Lab Ltd$250M · Nov 9Biotechnology AI3 Bio, Inc.$48.3M · Nov 4Biotechnology XRHealth, Inc.$16.3M · Oct 23Other Health Care Crosslink Therapeutics Inc.$5.5M · Oct 20Pharmaceuticals Fresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care BridgeHealth Pharmaceuticals, Inc.$3.5M · Nov 5Pharmaceuticals Quiver Holdings Inc.$3M · Oct 21Biotechnology Nocturnal Inc.$1.9M · Oct 20Other Health Care